Nanosphere Health Sciences Inc

STU:2CG2 (Canada)  
€ 0.01 (-23.08%) Nov 29
At Loss
Market Cap:
€ 243.00K ($ 256.00K)
Enterprise V:
€ 251.00K ($ 264.00K)
Volume:
-
Avg Vol (2M):
1.19K
Trade In:

Business Description

Description
Nanosphere Health Sciences Inc is a nano-biotechnology company. The company is focused on providing next-generation delivery of nutritive elements and medications. Its NanoSphere Delivery System platform technology addresses the problems of low bioavailability and excessive dosage amounts of a wide range of bioactive compounds. It focuses on developing nanoencapsulation technology for the delivery of nutritive elements and medicants through licensing arrangements.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.76
Equity-to-Asset -49.62
Debt-to-Equity -0.02
Debt-to-EBITDA -0.15
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 25.7
9-Day RSI 32.29
14-Day RSI 36.96
6-1 Month Momentum % 64.71
12-1 Month Momentum % 833.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.02
Quick Ratio 0.02
Cash Ratio 0.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -23.8

Profitability Rank

Name Current Vs Industry Vs History
ROA % -822.09
ROIC % -678.05

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -1.31
EV-to-EBITDA -1.31
EV-to-FCF -26.5
Earnings Yield (Greenblatt) % -76.34
FCF Yield % -3.89

Financials

STU:2CG2's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Nanosphere Health Sciences Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) -0.017
Beta 1.65
Volatility % 505.33
14-Day RSI 36.96
14-Day ATR (€) 0.001984
20-Day SMA (€) 0.009625
12-1 Month Momentum % 833.33
52-Week Range (€) 0.0005 - 0.0415
Shares Outstanding (Mil) 10.28

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nanosphere Health Sciences Inc Filings

Filing Date Document Date Form
No Filing Data

Nanosphere Health Sciences Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Nanosphere Health Sciences Inc Frequently Asked Questions

What is Nanosphere Health Sciences Inc(STU:2CG2)'s stock price today?
The current price of STU:2CG2 is €0.01. The 52 week high of STU:2CG2 is €0.04 and 52 week low is €0.00.
When is next earnings date of Nanosphere Health Sciences Inc(STU:2CG2)?
The next earnings date of Nanosphere Health Sciences Inc(STU:2CG2) is .
Does Nanosphere Health Sciences Inc(STU:2CG2) pay dividends? If so, how much?
Nanosphere Health Sciences Inc(STU:2CG2) does not pay dividend.

Press Release

Subject Date
No Press Release